| abstract |
A device-based risk management method in treatments having contraindications and / or side effects. A request to register a prescriber with an RMS host device is received 210, and in response, educational information / material is provided to the prescriber 220, including authentication including access to an authentication test associated with the material. Information is provided 230 to the prescriber, the prescriber undergoes an authentication test, such as at the prescriber's computing device, and the host device receives an identifier of the prescriber's performance regarding the test 240, and the prescriber's performance is the test. If the performance criteria are met, the prescriber is registered 250 with the RMS at the host device. [Selection] Figure 2 |